KEYTRUDA: Merck have announced their anti-PD-1 therapy for the treatment of certain patients with locally advanced or metastatic urothelial carcinoma has been recommended for
31 Jul, 2017
31 Jul, 2017
Two signals were detected from EU Spontaneous Reporting Systems • Ritonavir NORVIR, lopinavir, ritonavir – KALETRA; levothyroxine: a signal of interaction possibly
31 Jul, 2017
During its July meeting, the European Medicines Agency’s (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) concluded two referrals and continued its evaluation of six
The EMA published a press release on 16 June 2017, announcing the entry of force of the Clinical Trial Regulation has been delayed until 2019. At the EMA management board
Legislation in Poland reducing women’s access to the morning after pill has been widely condemned as an affront to European values. The new law requires the contraceptive to
10 Jul, 2017
In December 2016, the MHRA classified cannabis oil as a medicine, which contains cannabidiol (CBD) but does not contain tetrahydrocannabinol (THC) which induces a ‘high’ or
10 Jul, 2017
Adverse drug reaction (ADR) reporting relies on HCPs and patients reporting these events in order to make medications safe. However, the MHRA is still finding that ADRs are
A new study published in the international journal CNS Drugs this month has identified the need for urgent updated guidance for the anti-psychotic drug clozapine, used to
The EMA has allocated working groups with distributing workloads in anticipation of Brexit in March 2019. The EMA is keen to ensure business continuity without any disruption
10 Jul, 2017
A secret ballot is due to be held by the EU to determine which Member State will be the next host for the EMA and the EBA. Both the European Medicines Agency (EMA) and the
